FDA chief Gottlieb ‘names and shames’ big pharma for delaying generic competition

When Dr. Scott Gottlieb, commissioner of the Food and Drug Administration, publicly listed pharmaceutical companies that have “potentially blocked access” to samples of their branded products to generic drug developers —...

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@ftcwatch.com
Phone: 202-909-2156

Try FTCWatch FREE for 30 days

FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch

Current Issue: 963
Next Issue: Jul 2, 2019

Browse Archives

In this Issue:

Auto software firm settles data breach case
Vaping companies get warnings from FTC, FDA
Wilson reflects on uplifting women lawyers in antitrust field
Calendar
Judge tries to breathe new life into Tunney Act, but odds are long
One-ring phone scam resurfaces, FTC warns
US's Google probe may build on Australia, UK reviews of digital advertising
Canon, Toshiba to pay $5 million for antitrust violations
FTC examines tricky world of online tickets
Senator Lee reignites antitrust turf debate
‘Remarkable’ Qualcomm case puts spotlight on dissents
Congress flexes muscles on antitrust — again
Neil Averitt commentary: The Doric simplicity of the Qualcomm opinion
People
T-Mobile suit by states sets precedent, defies FCC, pressures DOJ
Playing the FOIA waiting game
Consumer watchdog accuses FTC of regulatory capture
Presidential candidates pitch progressive antitrust solutions to farmers
Hawley pushes privacy bills to bolster FTC enforcement powers
FCC's T-Mobile fix includes carrots for DOJ, states

RSS Feed